LEADER 01508nam  2200421Ia 450 
001 9910703243903321
005 20111012092156.0
035   $a(CKB)4970000000040828
035   $a(OCoLC)756756815
035   $a(EXLCZ)994970000000040828
100   $a20111012d2011      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aMedicare Part D formularies$b[electronic resource] $eCMS conducts oversight of mid-year changes; most mid-year changes were enhancements /$f[Kathleen M. King]
210  1$aWashington, DC :$cU.S. Govt. Accountability Office,$d[2011]
215   $a1 online resource (17 pages) $cillustrations
300   $aTitle from PDF title screen (viewed Sept. 26, 2011).
300   $a"June 30, 2011."
300   $a"GAO-11-366R."
320   $aIncludes bibliographical references.
517   $aMedicare Part D Formularies
606   $aMedicare beneficiaries
606   $aMedicine$zUnited States$vFormulae, receipts, prescriptions
606   $aPharmaceutical services insurance$zUnited States
615  0$aMedicare beneficiaries.
615  0$aMedicine
615  0$aPharmaceutical services insurance
700   $aKing$b Kathleen M$01383406
712 02$aUnited States.$bGovernment Accountability Office.
801  0$bGPO
801  1$bGPO
906   $aDOCUMENT
912   $a9910703243903321
996   $aMedicare Part D formularies$93519247
997   $aUNINA